Several widely used Java frameworks and tools released new versions in the weeks surrounding Oracle's March 17 launch of JDK 26, as the Spring ecosystem and related projects continued iterating toward ...

Diffblue today announced the general availability of the Diffblue Testing Agent, an autonomous regression test generator that ...

Survival outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving lutetium Lu 177 vipivotide tetraxetan (Lu) by prior taxane exposure. Overall survival (OS) in ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

LITTLE ROCK, Ark. (KATV) — It’s a question so many women have asked: "If my mother had breast cancer, will I get it too?" But doctors say knowledge is power, and that power could save your life. UAMS ...

MOBSTA is a robustness testing tool for ROS that tests autonomous systems under realistic but rare conditions that are not represented in training data and difficult to replicate during field testing.

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today. Breelyn Wilky, MD, the director of Sarcoma Medical Oncology at the University ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

The SERENA-6 trial focused on ESR1 mutation detection in metastatic HR-positive, HER2-negative breast cancer to extend first-line treatment efficacy. Serial liquid biopsies were used to identify ESR1 ...